Bohai Pharmaceuticals Appoints Marcum Bernstein & Pinchuk LLP as Independent Registered Public Accounting Firm
NEW YORK and YANTAI, China, July 1, 2011 (GLOBE NEWSWIRE) -- Bohai Pharmaceuticals Group, Inc. (OTCBB:BOPH) a China-based pharmaceutical company engaged in the production, manufacturing and distribution of modernized traditional Chinese medicine (TCM) in China, today announced that the audit committee of the company's board of directors has appointed Marcum Bernstein & Pinchuk LLP as the company's new independent registered public accounting firm.
Mr. Hongwei Qu, Chairman, President and CEO of Bohai Pharmaceuticals, stated, "Given the rapid growth in our business, we decided for the benefit of our company and our shareholders to engage one of the largest independent accounting firms in the U.S. Marcum has a strong global reputation and extensive expertise and physical presence in the China market, which we believe reinforces our commitment to the highest levels of transparency and strong corporate governance." http://finance.yahoo.com/news/Bohai-Pharmaceuticals-pz-2606696434.html?x=0&.v=1
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.